Skip to content
ClinCalc Pro
Menu
First-Generation Cephalosporin (Surgical Prophylaxis)

Cefazolin

Brand names: Kefzol

This entry covers cefazolin used as intravenous surgical antibiotic prophylaxis in orthopaedic and trauma surgery, including arthroplasty and fracture fixation; it is a first-generation cephalosporin.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Cefazolin binds penicillin-binding proteins to inhibit bacterial cell-wall peptidoglycan synthesis, giving bactericidal activity against common skin staphylococci and streptococci responsible for surgical-site infection.

Prescribing in practice

  • Give within the recommended window before skin incision to achieve adequate tissue concentrations at the time of surgery, with redosing for prolonged procedures or major blood loss per protocol.
  • Avoid in patients with a history of severe immediate hypersensitivity to penicillins or cephalosporins, and consider an alternative where MRSA cover is required.
  • Adjust dosing in significant renal impairment, as cefazolin is renally cleared.

Monitoring

Monitor for hypersensitivity reactions around administration and review renal function where repeated or prolonged dosing is needed.

Counselling the patient

  • This antibiotic is given at the time of your operation to lower the risk of wound infection.
  • Tell the team about any previous reaction to penicillins or cephalosporins before it is given.

Evidence & guidelines

First-generation cephalosporins such as cefazolin are recommended as standard surgical antibiotic prophylaxis in orthopaedic surgery by SIGN and other guidance.

Reference: SIGN 104 (Antibiotic Prophylaxis in Surgery); NICE NG125; Classen et al. NEJM 1992; SPC Kefzol; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.